|
Originally published In Press as doi:10.1194/jlr.M600403-JLR200 on December 20, 2006
Journal of Lipid Research, Vol. 48, 592-599, March 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology
Role of LCAT in HDL remodeling: investigation of LCAT deficiency states
Bela F. Asztalos1,*,
Ernst J. Schaefer*,
Katalin V. Horvath*,
Shizuya Yamashita ,
Michael Miller ,
Guido Franceschini** and
Laura Calabresi**
* Lipid Metabolism Laboratory, Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA
Department of Internal Medicine and Molecular Science, Osaka University, Suita, Japan
Department of Medicine, University of Maryland, Baltimore, MD
** Center E Grossi Paoletti, Department of Pharmacological Sciences, University of Milan, Milan, Italy
Published, JLR Papers in Press, December 20, 2006.
1 To whom correspondence should be addressed. e-mail: bela.asztalos{at}tufts.edu
To better understand the role of LCAT in HDL metabolism, we compared HDL subpopulations in subjects with homozygous (n = 11) and heterozygous (n = 11) LCAT deficiency with controls (n = 22). Distribution and concentrations of apolipoprotein A-I (apoA-I)-, apoA-II-, apoA-IV-, apoC-I-, apoC-III-, and apoE-containing HDL subpopulations were assessed. Compared with controls, homozygotes and heterozygotes had lower LCAT masses (77% and 13%), and LCAT activities (99% and 39%), respectively. In homozygotes, the majority of apoA-I was found in small, disc-shaped, poorly lipidated preß-1 and -4 HDL particles, and some apoA-I was found in larger, lipid-poor, discoidal HDL particles with -mobility. No apoC-I-containing HDL was noted, and all apoA-II and apoC-III was detected in lipid-poor, preß-mobility particles. ApoE-containing particles were more disperse than normal. ApoA-IV-containing particles were normal. Heterozygotes had profiles similar to controls, except that apoC-III was found only in small HDL with preß-mobility. Our data are consistent with the concepts that LCAT activity: 1) is essential for developing large, spherical, apoA-I-containing HDL and for the formation of normal-sized apoC-I and apoC-III HDL; and 2) has little affect on the conversion of preß-1 into -4 HDL, only slight effects on apoE HDL, and no effect on apoA-IV HDL particles.
Supplementary key words HDL subpopulations apolipoproteins reverse cholesterol transport Abbreviations: apoA-I, apolipoprotein A-I; CAD, coronary artery disease; CETP, cholesteryl ester transfer protein; EL, endothelial lipase; FC, free cholesterol; FED, fish eye disease; FLD, familial LCAT deficiency; HDL-C, HDL cholesterol; sPLA2, secretory phospholipase A2; SR-BI, scavenger receptor type B-I; TG, triglyceride

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Anuurad, M. Yamasaki, N. Shachter, T. A. Pearson, and L. Berglund
ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans
J. Lipid Res.,
July 1, 2009;
50(7):
1472 - 1478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Massey, H. J. Pownall, S. Macha, J. Morris, M. R. Tubb, and R. A. G. D. Silva
Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particles
J. Lipid Res.,
June 1, 2009;
50(6):
1229 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Hirsch-Reinshagen, J. Donkin, S. Stukas, J. Chan, A. Wilkinson, J. Fan, J. S. Parks, J. A. Kuivenhoven, D. Lutjohann, H. Pritchard, et al.
LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins
J. Lipid Res.,
May 1, 2009;
50(5):
885 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Sacks, L. L. Rudel, A. Conner, H. Akeefe, G. Kostner, T. Baki, G. Rothblat, M. de la Llera-Moya, B. Asztalos, T. Perlman, et al.
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
J. Lipid Res.,
May 1, 2009;
50(5):
894 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Millar, D. Duffy, R. Gadi, L. T. Bloedon, R. L. Dunbar, M. L. Wolfe, R. Movva, A. Shah, I. V. Fuki, M. McCoy, et al.
Potent and Selective PPAR-{alpha} Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2009;
29(1):
140 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Thomas, S. Bhat, and M. G. Sorci-Thomas
Three-dimensional models of HDL apoA-I: implications for its assembly and function
J. Lipid Res.,
September 1, 2008;
49(9):
1875 - 1883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lamon-Fava, D. M. Herrington, D. M. Reboussin, M. Sherman, K. V. Horvath, L. A. Cupples, C. White, S. Demissie, E. J. Schaefer, and B. F. Asztalos
Plasma Levels of HDL Subpopulations and Remnant Lipoproteins Predict the Extent of Angiographically-Defined Coronary Artery Disease in Postmenopausal Women
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2008;
28(3):
575 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al.
Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency
J. Lipid Res.,
February 1, 2008;
49(2):
349 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|